profits
slide
indias
dr
reddy
profits
indian
drugmaker
dr
reddys
fell
research
costs
rose
sales
flagged
firm
said
profits
rupees
â£
three
months
december
sales
fell
bn
rupees
dr
reddys
built
reputation
producing
generic
versions
bigname
pharmaceutical
products
competition
intensified
firm
company
short
new
product
launches
recent
annoucement
december
exclusive
marketing
rights
generic
version
famous
antidepressant
prozac
maker
eli
lilly
also
lost
key
court
case
march
banning
selling
version
pfizers
popular
hypertension
drug
norvasc
us
research
development
new
drugs
continuing
apace
rd
spending
rising
rupees
key
cause
decrease
profits
alongside
fall
sales
patents
number
wellknown
products
due
run
near
future
representing
opportunity
dr
reddy
whose
shares
listed
new
york
indian
generics
manufacturers
sales
dr
reddys
generics
business
fell
rupees
another
staple
firms
business
sale
ingredients
drugs
also
performed
poorly
sales
previous
year
bn
rupees
face
strong
competition
home
us
europe
dr
reddys
indian
competitors
gathering
strength
although
face
heavy
competitive
pressures
